My ePortfolio Register   

New personalised therapies for lung cancer

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 04.06.17
Views: 2008

Dr Luis Raez - Memorial Cancer Institute, Hollywood, Florida, USA

Dr Luiz Raez speaks with ecancer at ASCO 2017 about new developments and discoveries in the field of personalised medicine, particularly in lung cancer patients.

He mentions that the standard of care currently includes testing new lung cancer patients for molecular markers, and that in 20% of patients, markers are present, allowing for personalised therapy.

The breadth and number of abstracts dealing with immunotherapy treatments at ASCO 2017 is promising for the field, he says.


Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence